Chugai Pharmaceutical Co Stock Revenue
CHGCY Stock | USD 16.79 0.15 0.90% |
Chugai Pharmaceutical Co fundamentals help investors to digest information that contributes to Chugai Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Chugai Pink Sheet. The fundamental analysis module provides a way to measure Chugai Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chugai Pharmaceutical pink sheet.
Chugai |
Chugai Pharmaceutical Co Company Revenue Analysis
Chugai Pharmaceutical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Chugai Pharmaceutical Revenue | 999.76 B |
Most of Chugai Pharmaceutical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Chugai Pharmaceutical Co reported 999.76 B of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The revenue for all United States stocks is significantly lower than that of the firm.
Chugai Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chugai Pharmaceutical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Chugai Pharmaceutical could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics of similar companies.Chugai Pharmaceutical is currently under evaluation in revenue category among related companies.
Chugai Fundamentals
Return On Equity | 0.29 | |||
Return On Asset | 0.2 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.42 % | |||
Current Valuation | 39.67 B | |||
Shares Outstanding | 3.29 B | |||
Price To Earning | 22.15 X | |||
Price To Book | 4.62 X | |||
Price To Sales | 0.04 X | |||
Revenue | 999.76 B | |||
Gross Profit | 783.7 B | |||
EBITDA | 419.43 B | |||
Net Income | 303 B | |||
Cash And Equivalents | 545.3 B | |||
Cash Per Share | 165.74 X | |||
Total Debt | 16.04 B | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 3.21 X | |||
Book Value Per Share | 432.94 X | |||
Cash Flow From Operations | 279.63 B | |||
Earnings Per Share | 0.86 X | |||
Price To Earnings To Growth | 17.34 X | |||
Number Of Employees | 43 | |||
Beta | 0.52 | |||
Market Capitalization | 44.63 B | |||
Total Asset | 1.54 T | |||
Retained Earnings | 500.19 B | |||
Working Capital | 435.19 B | |||
Current Asset | 542.89 B | |||
Current Liabilities | 107.7 B | |||
Z Score | 1.2 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.37 % | |||
Net Asset | 1.54 T | |||
Last Dividend Paid | 78.0 |
About Chugai Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chugai Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chugai Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chugai Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Chugai Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chugai Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Chugai Pink Sheet
0.65 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Chugai Pink Sheet
0.77 | EC | Ecopetrol SA ADR Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chugai Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chugai Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chugai Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chugai Pharmaceutical Co to buy it.
The correlation of Chugai Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chugai Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chugai Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chugai Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chugai Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |